Cytori Therapeutics Inc (CYTX.OQ)
2.55USD
1:55pm EDT
$0.01 (+0.39%)
$2.54
$2.54
$2.60
$2.53
11,675
78,560
$4.91
$2.06
CYTX.OQ
About
Overall
| Beta: | 0.82 |
| Market Cap (Mil.): | €132.21 |
| Shares Outstanding (Mil.): | 67.17 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CYTX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 30.14 | 35.13 |
| EPS (TTM): | -0.46 | -- | -- |
| ROI: | -78.90 | 10.40 | 18.83 |
| ROE: | -286.17 | 13.41 | 19.68 |
Medical device maker Cytori loses approval fight
WASHINGTON - An appeals court ruled on Friday that the Food and Drug Administration acted correctly when it denied fast-track approval of two stem cell-related medical devices made by Cytori Therapeutics Inc.
UPDATE 1-Medical device maker Cytori loses approval fight
WASHINGTON, March 22 - A U.S. appeals court ruled on Friday that the Food and Drug Administration acted correctly when it denied fast-track approval of two stem cell-related medical devices made by Cytori Therapeutics Inc.
Medical device maker Cytori Therapeutics loses approval fight
WASHINGTON, March 22 - A U.S. appeals court ruled on Friday that the Food and Drug Administration (FDA) acted correctly when it denied fast-track approval of two stem cell-related medical devices made by Cytori Therapeutics Inc .
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
